- Report
- August 2023
- 145 Pages
Global
From €2826EUR$3,150USD£2,417GBP
- Report
- August 2025
- 197 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- August 2025
- 190 Pages
Global
From €3180EUR$3,545USD£2,721GBP
€3534EUR$3,939USD£3,023GBP
- Report
- March 2022
- 300 Pages
Global
From €4486EUR$5,000USD£3,837GBP
From €3140EUR$3,500USD£2,686GBP
- Report
- February 2025
- 85 Pages
India
From €3140EUR$3,500USD£2,686GBP
- Report
- December 2024
- 85 Pages
India
From €3140EUR$3,500USD£2,686GBP
- Report
- August 2025
- 183 Pages
Global
From €4037EUR$4,500USD£3,454GBP
- Report
- April 2025
- 85 Pages
Saudi Arabia
From €3140EUR$3,500USD£2,686GBP
- Report
- January 2025
- 133 Pages
Europe
From €3588EUR$4,000USD£3,070GBP
- Report
- August 2025
- 180 Pages
Global
From €4037EUR$4,500USD£3,454GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €3140EUR$3,500USD£2,686GBP
- Report
- December 2024
- 85 Pages
Spain
From €3140EUR$3,500USD£2,686GBP
- Report
- September 2024
- 80 Pages
Japan
From €3140EUR$3,500USD£2,686GBP
- Report
- September 2024
- 80 Pages
France
From €3140EUR$3,500USD£2,686GBP
- Report
- August 2024
- 80 Pages
Japan
From €3140EUR$3,500USD£2,686GBP
- Report
- April 2024
- 185 Pages
Global
From €4037EUR$4,500USD£3,454GBP
- Report
- October 2023
- 133 Pages
Europe
From €3588EUR$4,000USD£3,070GBP
- Report
- October 2023
- 138 Pages
Asia Pacific
From €3588EUR$4,000USD£3,070GBP
From €3140EUR$3,500USD£2,686GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more